MENUNews Archive
Date: 06/16/2020
Awards three outstanding young clinical researchers, two exceptional medical students and a powerhouse fellow.
Date: 06/12/2020
Researchers at the University of Michigan Rogel Cancer Center have identified a protein -- Argonaute 2 -- that appears to be critical for the progression of benign precursor lesions into pancreatic cancer. Argonaute 2 interacts with K-RAS, which helps relay signals from the outside of a cell to its nucleus. Mutations in the KRAS gene drive more than 90% of pancreatic cancers, and currently there are no therapies that target these mutations.
Date: 06/10/2020
A new $2 million grant from the National Cancer Institute will help University of Michigan Rogel Cancer Center researchers prepare the next generation of scientists focused on cancer care delivery.
Date: 06/02/2020
The Rogel Cancer Center joins with our communities of color, and all Americans, to express our outrage and heartbreak over the continued racism and injustice tearing at the fabric of civil society.
Date: 06/01/2020
The University of Michigan’s OncCOVID app draws on global cancer and coronavirus data to help people assess the risks to their lives by delaying cancer treatment.
Date: 05/29/2020
The Rogel Cancer Center offers updates, support for anxiety and stress, what cancer patients need to know, how to seek out cancer treatment during this time and ways you can support our staff. Michigan Medicine and the Rogel Cancer Center will continue to update the links and information on this page as the situation evolves.
Date: 05/20/2020
A group of a dozen U-M women researchers are pushing forward participating in ResearcHERs, an American Cancer Society campaign that gives women the opportunity to raise funds to fuel the work of female scientists.
Date: 05/20/2020
A new analytic tool developed by University of Michigan Rogel Cancer Center researchers combines multiple data sets to help sift the signal from the noise. Called transPRECISE, it can identify pre-clinical systems or potential treatments for multiple cancer types
Date: 05/13/2020
During the holy month this year, public health experts from the University of Michigan Rogel Cancer Center are partnering with the Dearborn-based nonprofit ACCESS on a culturally tailored smoking cessation campaign called Yallah Quit. Yallah is Arabic for “Let’s go!”
Date: 05/06/2020
The Forbes Institute for Cancer Research at the University of Michigan Rogel Cancer Center will fund two researchers pursuing promising new treatment approaches for brain and ovarian cancers. Maria G. Castro, Ph.D., and Deepak Nagrath, Ph.D., will receive one-year grants of $250,000 each as 2020 Forbes Scholars.